Aktuellt
SENASTE
Redeye strengthens its positive view of Transtema following a Q2 beating our expectations. While the Q2 numbers were on the soft side as expected (yet better than we expected), the most important takeaway is that the worst likely is over, and Transtema enters 2025 with a solid order backlog.
LÄS MER
